MD Biosciences new release

News & Events

Tuesday, May 1, 2012 MD Biosciences
A Rapid 10 day preclinical efficacy study that produces lesions highly representative of human psoriatic lesions. Wednesday, May 2, 2012, St. Paul, MN – The most common models for evaluating skin-related inflammation are time...Read More
Thursday, Aug 11, 2011 MD Biosciences
MD Biosciences , a Preclinical Contract Research Organization (CRO), offers in vivo models for the study of Parkinson's Disease (PD) . The 6-OHDA and acute MPTP models for PD have been well characterized with the underlying mechanisms of toxicity...Read More
Wednesday, Jul 13, 2011 MD Biosciences
MD Biosciences, a preclinical CRO focused in pain and inflammations, has released a new eBook discussing the interactions between the nervous and immune systems and the drug targets that may lie in the overlap. This newly published  eBook...Read More
Thursday, Feb 3, 2011 MD Biosciences
MD Biosciences, a global biotechnology company focused in inflammations research, has optimized  ArthritoMabTM Antibody Cocktail  for the induction of arthritis in C57Bl/6. Using the optimized  ArthritoMab Antibody Cocktail ,...Read More
Wednesday, Jun 16, 2010 MD Biosciences
Wednesday, June 16, 2010, St. Paul, MN - MD Biosciences, a Preclinical Contract Research Organization (CRO), offers in vivo models for the study of myocardial infarct (MI). The occlusion-induced myocardial infarct model is a well-known...Read More